Journal article icon

Journal article

An international comparison of retinopathy of prematurity grading performance within the Benefits of Oxygen Saturation Targeting II trials.

Abstract:

Purpose

To investigate whether the observed international differences in retinopathy of prematurity (ROP) treatment rates within the Benefits of Oxygen Saturation Targeting (BOOST) II trials might have been caused by international variation in ROP disease grading.

Methods

Groups of BOOST II trial ophthalmologists in UK, Australia, and New Zealand (ANZ), and an international reference group (INT) used a web based system to grade a selection of RetCam images of ROP ...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1038/eye.2017.150

Authors


Williams, C More by this author
More by this author
Department:
Oxford, MSD, Nuffield Dept of Population Health, NPEU
Stenson, BJ More by this author
Expand authors...
Medical Research Council More from this funder
National Health and Medical Research Council of Australia More from this funder
Health Research Council of New Zealand More from this funder
Royal College of Surgeons Edinburgh More from this funder
Royal Blind More from this funder
Expand funders...
Publisher:
Nature Publishing Group Publisher's website
Journal:
Eye Journal website
Publication date:
2017-07-05
Acceptance date:
2017-06-21
DOI:
EISSN:
1476-5454
ISSN:
0950-222X
Pubs id:
pubs:710305
URN:
uri:32813a8d-e7af-46c1-8192-268f1197fff9
UUID:
uuid:32813a8d-e7af-46c1-8192-268f1197fff9
Local pid:
pubs:710305

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP